Related references
Note: Only part of the references are listed.Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
Jinchao Zhang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Paradoxical roles for antioxidants in tumor prevention and eradication
Joseph E. De Larco et al.
CANCER BIOLOGY & THERAPY (2010)
Kinases as targets in the treatment of solid tumors
Georgios Giamas et al.
CELLULAR SIGNALLING (2010)
IAP antagonists: promising candidates for cancer therapy
Raimund Mannhold et al.
DRUG DISCOVERY TODAY (2010)
Targeting Mitochondria for Cancer Therapy
David M. Hockenbery
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2010)
Human telomeric G-quadruplex: The current status of telomeric G-quadruplexes as therapeutic targets in human cancer
Stephen Neidle
FEBS JOURNAL (2010)
Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors
Chun-Meng Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Chronic myeloid leukemia: mechanisms of blastic transformation
Danilo Perrotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Proteases implicated in apoptosis: old and new
Kelly L. Moffitt et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Oxidative stress in NSC-741909-induced apoptosis of cancer cells
Xiaoli Wei et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger
Stephen J. Ralph et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
The causes of cancer revisited: Mitochondrial malignancy and ROS-induced oncogenic transformation - Why mitochondria are targets for cancer therapy
Stephen J. Ralph et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Vitamin E neuroprotection for cisplatin neuropathy A randomized, placebo-controlled trial
A. Pace et al.
NEUROLOGY (2010)
The 26S proteasome: assembly and function of a destructive machine
Nerea Gallastegui et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Novel Molecular Mechanism for Actinomycin D Activity as an Oncogenic Promoter G-Quadruplex Binder
Hyun-Jin Kang et al.
BIOCHEMISTRY (2009)
Targeting the telosome: Therapeutic implications
Marco Folini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Proteomics of the lysosome
Torben Luebke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Cysteine cathepsins are not critical for TNF-α-induced cell death in T98G and U937 cells
Martina Klaric et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
D. Chen et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications
Yvette Drew et al.
DRUG RESISTANCE UPDATES (2009)
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)
Marie Magnusson et al.
EUROPEAN JOURNAL OF CANCER (2009)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Teni Boulikas
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Lysosomes as Suicide Bags in Cell Death: Myth or Reality?
Boris Turk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Control of mitochondrial apoptosis by the Bcl-2 family
Joslyn K. Brunelle et al.
JOURNAL OF CELL SCIENCE (2009)
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
RuiRong Yuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Is Glutathione the Major Cellular Target of Cisplatin? A Study of the Interactions of Cisplatin with Cancer Cell Extracts
Yonit Kasherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The molecular composition of the mitochondrial permeability transition pore
Christopher P. Baines
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
New glycosylated derivatives of versipelostatin, the GRP78/Bip molecular chaperone down-regulator, from Streptomyces versipellis 4083-SVS6
Ping Zhao et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Sunitinib Treatment in Pediatric Patients With Advanced GIST Following Failure of Imatinib
Katherine A. Janeway et al.
PEDIATRIC BLOOD & CANCER (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Cancer cell killing via ROS To increase or decrease, that is the question
Jie Wang et al.
CANCER BIOLOGY & THERAPY (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Apoptosis and non-apoptotic deaths in cancer development and treatment response
Elza C. de Bruin et al.
CANCER TREATMENT REVIEWS (2008)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
Proteasome inhibitors in cancer therapy: Lessons from the first decade
Robert Z. Orlowski et al.
CLINICAL CANCER RESEARCH (2008)
DNA damage detection and repair pathways - Recent advances with inhibitors of checkpoint kinases in cancer therapy
Susan Ashwell et al.
CLINICAL CANCER RESEARCH (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
DNA damage repair and response proteins as targets for cancer therapy
Howard B. Lieberman
CURRENT MEDICINAL CHEMISTRY (2008)
2-Deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer
Mitchell C. Coleman et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Cysteine cathepsins trigger caspase-dependent cell death through cleavage of Bid and antiapoptotic Bcl-2 homologues
Gabriela Droga-Mazovec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Caspases in apoptosis and beyond
J. Li et al.
ONCOGENE (2008)
The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family
H. M. Heath-Engel et al.
ONCOGENE (2008)
Lysosomal membrane permeabilization in cell death
P. Boya et al.
ONCOGENE (2008)
Nilotinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia
Anthony Jarkowski et al.
PHARMACOTHERAPY (2008)
Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes
Peter Kijun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Telomere dysfunction and tumour suppression: the senescence connection
Yibin Deng et al.
NATURE REVIEWS CANCER (2008)
Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells
Meenakshi Tiwari et al.
CARCINOGENESIS (2008)
MGMT inhibitors - The Trinity College-Paterson Institute experience, a chemist's perception
T. Brian et al.
DNA REPAIR (2007)
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
Mathias Schmidt et al.
DRUG RESISTANCE UPDATES (2007)
Regulated externalization of phosphatidylserine at the cell surface - Implications for apoptosis
Krishnakumar Balasubramanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Protease signalling in cell death: caspases versus cysteine cathepsins
Boris Turk et al.
FEBS LETTERS (2007)
Apoptosis induced by the lymphocyte effector molecule perforin
Paul Bolitho et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization
Robert Blomgran et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Role of the mitochondrial membrane permeability transition in cell death
Yoshihide Tsujimoto et al.
APOPTOSIS (2007)
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death
Christopher P. Baines et al.
NATURE CELL BIOLOGY (2007)
GRP78 induction in cancer: Therapeutic and prognostic implications
Amy S. Lee
CANCER RESEARCH (2007)
Ubiquitination of RIP1 regulates an NF-κB independent cell-death switch in TNF signaling
Marie Anne O'Donnell et al.
CURRENT BIOLOGY (2007)
The Role of Sulfur in Platinum Anticancer Chemotherapy
Xiaoyong Wang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Cell death by necrosis: towards a molecular definition
Pierre Golstein et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Acid ceramidase and human disease
Jae-Ho Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Autophagy is activated for cell survival after endoplasmic reticulum stress
Maiko Ogata et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response
Nele Festjens et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Pharmacodynamic properties of methotrexate and Aminotrexate™ during weekly therapy
PD Cole et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells
NS Nagaraj et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Cathepsin-regulated apoptosis
CE Chwieralski et al.
APOPTOSIS (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Inactivation of O-6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2006)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Golgi structure in stress sensing and apoptosis
SW Hicks et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death
CP Baines et al.
NATURE (2005)
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death
T Nakagawa et al.
NATURE (2005)
The RIP kinases: crucial integrators of cellular stress
E Meylan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Antitumor antibiotics: Bleomycin, endiynes, and mitomycin
U Galm et al.
CHEMICAL REVIEWS (2005)
Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis
H Erdal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy
GM Cragg et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of bid by multiple papain-like lysosomal cathepsins
T Cirman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
Effect on tumor cells of blocking survival response to glucose deprivation
HR Park et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Calnexin suppresses GD3 synthase-induced apoptosis
B Tomassini et al.
FASEB JOURNAL (2004)
Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis
J Pardo et al.
JOURNAL OF CELL BIOLOGY (2004)
Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors:: Comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death
B Kaina et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1)
MK Houseweart et al.
CELL DEATH AND DIFFERENTIATION (2003)
Regulation of apoptosis by endoplasmic reticulum pathways
DG Breckenridge et al.
ONCOGENE (2003)
The Bcl-2 family: roles in cell survival and oncogenesis
S Cory et al.
ONCOGENE (2003)
Discovery, characterization, and structure - Activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins
S Kitada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor
ZS Fan et al.
CELL (2003)
Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition
IS Goping et al.
IMMUNITY (2003)
Necrosis: a specific form of programmed cell death?
SY Proskuryakov et al.
EXPERIMENTAL CELL RESEARCH (2003)
GD3 ganglioside and apoptosis
F Malisan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Functional significance of the perforin/granzyme cell death pathway
JA Trapani et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-α
C García-Ruiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Implication of mitochondria-derived ROS and cardiolipin peroxiclation in N-(4-hydroxyphenyl)retinamide-induced apoptosis
A Asumendi et al.
BRITISH JOURNAL OF CANCER (2002)
Telomeres, aging and cancer: In search of a happy ending
S Kim et al.
ONCOGENE (2002)
Organelle-specific initiation of cell death pathways
KF Ferri et al.
NATURE CELL BIOLOGY (2001)
The role of protein phosphorylation in human health and disease - Delivered on June 30th 2001 at the FEBS Meeting in Lisbon
P Cohen
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Phosphatidylserine, a death knell
RA Schlegel et al.
CELL DEATH AND DIFFERENTIATION (2001)
Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor
L Foghsgaard et al.
JOURNAL OF CELL BIOLOGY (2001)
Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex
M Orlowski et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
ME Guicciardi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion
MR Rippo et al.
FASEB JOURNAL (2000)
Poly(ADP-ribose) polymerase-1 in the nervous system
HC Ha et al.
NEUROBIOLOGY OF DISEASE (2000)
Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?
S Shall et al.
MUTATION RESEARCH-DNA REPAIR (2000)
DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis
DA Thomas et al.
IMMUNITY (2000)
Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving bid
M Barry et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Induction of cell death by the lysosomotropic detergent MSDH
W Li et al.
FEBS LETTERS (2000)
Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis
M Mancini et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
